XML 17 R6.htm IDEA: XBRL DOCUMENT v3.21.2
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 6 Months Ended
Jul. 03, 2021
Jun. 27, 2020
Cash flows from operating activities:    
Net income $ 315,419 $ 176,491
Adjustments to reconcile net income to net cash provided by operating activities:    
Stock-based compensation 15,596 18,122
Deferred income taxes 6,107 (777)
Depreciation 34,891 33,220
Amortization of intangibles 29,852 26,983
Change in operating assets and liabilities:    
Decrease in accounts receivable 18,985 86,978
Increase in inventories (50,873) (27,089)
Increase in other current assets (10,600) (14,699)
(Increase) decrease in other assets (9,263) 8,238
(Decrease) increase in accounts payable and other current liabilities (35,328) 34,714
Increase in deferred revenue and customer advances 91,631 37,558
Decrease in other liabilities (44,973) (29,293)
Net cash provided by operating activities 361,444 350,446
Cash flows from investing activities:    
Additions to property, plant, equipment and software capitalization (76,889) (97,029)
Business acquisitions, net of cash acquired 0 (76,664)
Investment in unaffiliated companies 0 (3,350)
Payments for intellectual property licenses (7,000)  
Purchases of investments (215,140) (16,828)
Maturities and sales of investments 17,923 1,536
Net cash used in investing activities (281,106) (192,335)
Cash flows from financing activities:    
Proceeds from debt issuances 500,000 315,000
Payments on debt (250,000) (300,366)
Payments of debt issuance costs (3,637) 0
Proceeds from stock plans 45,036 14,739
Purchases of treasury shares (341,507) (196,297)
Proceeds from derivative contracts 1,917 7,558
Net cash used in financing activities (48,191) (159,366)
Effect of exchange rate changes on cash and cash equivalents (8,786) 4,576
Increase in cash and cash equivalents 23,361 3,321
Cash and cash equivalents at beginning of period 436,695 335,715
Cash and cash equivalents at end of period $ 460,056 $ 339,036